Xenon Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.

About XENE

Xenon Pharmaceuticals, Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. 

CEO
Ian C. Mortimer
CEOIan C. Mortimer
Employees
370
Employees370
Headquarters
Burnaby, British Columbia
HeadquartersBurnaby, British Columbia
Founded
1996
Founded1996
Employees
370
Employees370

XENE Key Statistics

Market cap
5.55B
Market cap5.55B
Price-Earnings ratio
-12.09
Price-Earnings ratio-12.09
Dividend yield
Dividend yield
Average volume
684.61K
Average volume684.61K
High today
$58.15
High today$58.15
Low today
$42.00
Low today$42.00
Open price
$57.60
Open price$57.60
Volume
1.83M
Volume1.83M
52 Week high
$72.66
52 Week high$72.66
52 Week low
$35.97
52 Week low$35.97

Stock Snapshot

The current Xenon Pharmaceuticals(XENE) stock price is $42.79, with a market capitalization of 5.55B. The stock trades at a price-to-earnings (P/E) ratio of -12.09.

On 2026-09-18, Xenon Pharmaceuticals(XENE) stock moved within a range of $42.00 to $58.15. With shares now at $42.79, the stock is trading +1.9% above its intraday low and -26.4% below the session's peak.

Trading activity shows a volume of 1.83M, compared to an average daily volume of 684.61K.

The stock's 52-week range extends from a low of $35.97 to a high of $72.66.

The stock's 52-week range extends from a low of $35.97 to a high of $72.66.

XENE News

Benzinga 1h
Xenon Pharmaceuticals Shares Fall 25% After Hours: Here's Why

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) shares fell 25.39% to $42.79 in after-hours trading Thursday after the company announced a temporary pause in enrollmen...

Xenon Pharmaceuticals Shares Fall 25% After Hours: Here's Why
Reuters 9h
Xenon pauses new enrollment in depression drug trials over side-effect concerns - reuters.com

...

Xenon pauses new enrollment in depression drug trials over side-effect concerns - reuters.com
TipRanks 11h
Xenon Files FDA NDA for Azetukalner in Focal Seizures and Pauses New Psychiatry Enrollment

Xenon ( (XENE) ) just unveiled an update. Xenon Pharmaceuticals has submitted a New Drug Application to the U.S. Food and Drug Administration for azetukalner t...

Analyst ratings

94%

of 18 ratings
Buy
94.4%
Hold
5.6%
Sell
0%

More XENE News

TipRanks 11h
Xenon Pharmaceuticals submits azetukalner NDA to FDA

Xenon Pharmaceuticals (XENE) announced it has submitted a new drug application, or NDA, for azetukalner in focal seizures, or FS, to the FDA. The NDA submission...

People also own

Based on the portfolios of people who own XENE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.